Clinical Development Scientist – Lilly Gene Therapy, Sensory

Chester, Maryland, United States

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates must possess a Bachelor's degree in the Life Sciences and a minimum of two years of pharmaceutical and/or clinical experience. Qualified applicants must be authorized to work in the United States on a full-time basis, as Lilly will not provide work authorization or visa sponsorship. A Master's or higher-level degree is preferred, along with experience in global clinical trials within the rare disease area, clinical/investigational pharmacy with gene therapy products, or clinical supply management. Prior pharma/biotech or academic experience in rare disease, otology, audiology, gene therapy, cellular therapy, and/or medical device development is also preferred.

Responsibilities

The Clinical Development Scientist will manage the implementation of clinical supply and device trainings, including developing and updating training materials. They will collaborate cross-functionally to support the clinical and scientific execution of Lilly Gene Therapy clinical and preclinical programs, ensuring timely planning, implementation, management, and reporting of clinical studies. Responsibilities include serving as the clinical development representative to Clinical Supply Management for supply management, demand forecasting, and logistics, and acting as the clinical/scientific representative for assigned clinical trials and program teams. The role also involves supporting the clinical operations team in achieving trial deliverables, authoring and reviewing clinical/regulatory documents, and collaborating on regulatory strategy and communications.

Skills

Clinical Trial Management

Clinical Supply Management

Training Material Development

Clinical Study Implementation

Clinical Research

Preclinical Programs

Gene Therapy

CRO Support

Site Support

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free